<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2021-17-8-12</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-2105</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Результаты лечения инфаркта миокарда с подъемом сегмента ST с использованием ранних и отсроченных коронарных вмешательств в разных возрастных группах</article-title><trans-title-group xml:lang="en"><trans-title>Results of treatment of myocardial infarction with ST-segment elevation using early and delayed coronary interventions in different age groups</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5090-6212</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Газарян</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gazaryan</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Газарян Георгий Арташесович, д. м. н., проф.</p></bio><bio xml:lang="en"><p>Gazaryan George A., DM Sci, professor.</p><p>Moscow</p></bio><email xlink:type="simple">gigls@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нефедова</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nefedova</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нефедова Галина Александровна, к. м. н.</p></bio><bio xml:lang="en"><p>Nefedova Galina A., Phd Med.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9941-8885</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюрина</surname><given-names>Л. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Tyurina</surname><given-names>L. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тюрина Ляля Георгиевна</p></bio><bio xml:lang="en"><p>Tyurina Lyalya G.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3946-6153</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захаров</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharov</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Захаров Игорь Валерьевич, к. м. н.</p></bio><bio xml:lang="en"><p>Zakharov Igor, V., Phd Med.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермолов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ermolov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ермолов Александр Сергеевич, д. м. н., проф., член-корр. РАН</p></bio><bio xml:lang="en"><p>Ermolov Alexander S., DM Sci, professor, corr. member of RAS.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ г. Москвы «Научно-исследовательский институт скорой помощи имени Н. В. Склифосовского Департамента здравоохранения Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Emergency Care n. a. N. V. Sklifosovsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>17</day><month>08</month><year>2021</year></pub-date><volume>0</volume><issue>17</issue><issue-title>Кардиология и неотложная медицина (2)</issue-title><fpage>8</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Газарян Г.А., Нефедова Г.А., Тюрина Л.Г., Захаров И.В., Ермолов А.С., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Газарян Г.А., Нефедова Г.А., Тюрина Л.Г., Захаров И.В., Ермолов А.С.</copyright-holder><copyright-holder xml:lang="en">Gazaryan G.A., Nefedova G.A., Tyurina L.G., Zakharov I.V., Ermolov A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/2105">https://www.med-alphabet.com/jour/article/view/2105</self-uri><abstract><p>Целью работы явилась оценка результатов лечения больных с передним ИМ↑ST с использованием первичных ЧКВ в разных возрастных группах, в том числе при поздней госпитализации с учетом исходного риска смерти (РС). В исследование включено 804 больных с передним ИМ↑ST в возрасте от 28 до 91 года, поступивших в НИИ СП имени Н. В. Склифосовского с 2008 по 2017 год: из них 583 – с первичными ЧКВ, выполненными в первые 12 часов (311 больных) и при поздней госпитализации – через 12–72 часа (272 пациента), а также 221 больной без ЧКВ. Соотношение больных с ЧКВ у лиц младше 65, 65–75 и старше 75 лет составило 340, 139 и 104, без ЧКВ – 126, 47 и 48 соответственно. У 26 умерших после ЧКВ и 39 без вмешательств определяли состояние коронарного русла, площадь поражения миокарда и непосредственную причину смерти. Установлено, что при ИМ↑ST в отсутствии реперфузионной терапии (РТ) исходно высокому РС соответствует высокая летальность. Она складывается из лиц преимущественно пожилого и особенно старческого возраста, у которых чаще присутствует проксимальное поражение основных коронарных артерий, обусловливающее обширную площадь инфаркта с развитием фатальных осложнений. Применение первичных ЧКВ, в том числе при поздней госпитализации, позволяет предотвратить прогрессирование острой сердечной недостаточности, формирование аневризмы ЛЖ, сокращает частоту летальных исходов. В разные периоды уровень летальности при применении первичных ЧКВ, в том числе отсроченных, колеблется, он может повыситься при значительном увеличении госпитализированных старческого возраста. Повышение летальности ассоциируется с осложнениями, возникающими в том числе в ходе процедур при тяжелом многососудистом поражении КА, чаще присутствующем у этой категории больных. Достижение ангиографического успеха даже в отсутствие ЭКГ-признаков реперфузии позволяет существенно снизить летальность во всех возрастных группах. Высокий РС является оптимальным показанием для использования отсроченных процедур. Неотложное применение первичных ЧКВ, в том числе при поздней госпитализации, позволяет оптимизировать лечение ИМ↑ST, достичь максимального снижения летальности.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to assess the treatment results in patients with anterior STEMI using primary PCI in different patient age groups, including those at late hospitalization, taking into account the initial mortality risk (MR). The study included 804 patients with anterior STEMI, aged 28 to 91 years, who were admitted to N. V. Sklifosovsky Research Institute for Emergency Medicine in the period from 2008 to 2017: 583 of them had the primary PCI performed either within the first 12 hours from the disease onset (311 patients) or at late hospitalization: after 12–72 hours (272 patients); and 221 patients treated without PCI. The distribution of patients by age: under 65 years old, 65–75 years old, and over 75 years old was 340, 139, and 104 in the PCI group, and 126, 47, and 48 in the group without PCI, respectively. In 26 death cases after PCI and in 39 of died without interventions, the state of the coronary bed, the affected area, and the immediate cause of death were determined. We have found that in the absence of reperfusion therapy (RT) in STEMI, the initially high baseline MR assessed by TIMI Risk Score corresponds to high mortality. It affects people of predominantly elderly and, especially, senile age, who more often have a proximal lesion of the main coronary arteries, which causes an extensive area of infarction with the development of fatal complications. The use of primary PCIs, including those at late hospitalization, prevents the progression of acute heart failure, the formation of LV aneurysms, and reduces the deaths rate. In different periods of time, the mortality rate with the use of primary PCI, including the delayed ones, fluctuates; it can rise with a significantly increasing number of the hospitalized at senile age. An increase in mortality is associated with complications, including those arising during procedures in severe multivessel coronary artery disease, which is more common in this patient population. Achieving angiographic success even in the absence of ECG signs of reperfusion can significantly reduce mortality in all age groups. High MR is an optimal indication for using delayed procedures. An urgent use of primary PCIs, including those at late hospitalization, allows the optimization of the STEMI treatment, and the achievement of the maximum reduction in mortality.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт миокарда с подъемом сегмента ST</kwd><kwd>возрастные группы</kwd><kwd>пожилой и старческий возраст</kwd><kwd>первичные вмешательства до 12 часов и через 12–72 часа</kwd><kwd>ЭКГ-признаки реперфузии</kwd><kwd>ангиографический успех</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ST-segment elevation myocardial infarction</kwd><kwd>age groups</kwd><kwd>elderly and senile age</kwd><kwd>primary interventions within 12 hours and after 12–72 hours</kwd><kwd>ECG signs of reperfusion</kwd><kwd>angiographic success</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алтарев С.С, Барабаш О. Л., Помешкина С. А., Кашталап В. В., Зыков М. В., Тавлуева Е. В., Барабаш Л. С. Причины отказа от проведения реперфузионной терапии у пациентов с острым коронарным синдромом с подъемом сегмента ST. Кардиология 2012; 6. С. 4–9.</mixed-citation><mixed-citation xml:lang="en">Altarev S. S., Barabash O. L., Pomeshkina S. A., Kashtalap V. V., Zykov M. V., Tavlueva E. V., Barabash L. S. Reasons for refusing reperfusion therapy in patients with ST-segment elevation acute coronary syndrome. Cardiology 2012; 6. P. 4–9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">O’Gara P.T., Kushner F. G., Ascheim D. D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61. С. 485–510. doi.org/10.1161/CIR.0b013e3182742c84</mixed-citation><mixed-citation xml:lang="en">O’Gara P.T., Kushner F. G., Ascheim D. D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61. С. 485–510. doi.org/10.1161/CIR.0b013e3182742c84</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ibanez B., James S., Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018. No. 2. P. 119–177. DOI: 10.1093/eurheartj/ehx393.</mixed-citation><mixed-citation xml:lang="en">Ibanez B., James S., Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018. No. 2. P. 119–177. DOI: 10.1093/eurheartj/ehx393.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Saunderson C. E.D., Brogan R. A., Simms A. D. et al. Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges. Age and Ageing. 2014; 43: P. 450–455. DOI: 10.1093/ageing/afu034.</mixed-citation><mixed-citation xml:lang="en">Saunderson C. E.D., Brogan R. A., Simms A. D. et al. Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges. Age and Ageing. 2014; 43: P. 450–455. DOI: 10.1093/ageing/afu034.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Хубутия М. Ш., Газарян Г. А., Захаров И. В. Реперфузионная терапия в остром периоде инфаркта миокарда. 2010. С. 134–160.</mixed-citation><mixed-citation xml:lang="en">Khubutia M. Sh., Gazaryan G. A., Zakharov I. V. Reperfusion therapy in the acute period of myocardial infarction. 2010. P. 134–160.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Газарян Г. А., Честухин В. В., Захаров И. В., Ермолов А. С. Эффективность чрескожных коронарных вмешательств в остром периоде переднего инфаркта миокарда с учетом различной организации рентгенэндоваскулярной службы. Медицинский алфавит № 36/2020. Кардиология и неотложная медицина (4). С. 5–10. DOI: 10.33667/20785631–2020–36–5–10.</mixed-citation><mixed-citation xml:lang="en">Gazaryan G. A., Chestukhin V. V., Zakharov I. V., Ermolov A. S. Efficiency of percutaneous coronary interventions in the acute period of anterior myocardial infarction, taking into account the different organization of the X-ray endovascular service. Medical Alphabet No. 36/2020. Cardiology and emergency medicine (4). P. 5–10. DOI: 10.33667/2078–56312020–36–5–10.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow D. A., Antman E. M., Charlesworth A. et al. TIMI risk score for ST elevation myocardial infarction: a convenient, beside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infracting myocardium early II trial substudy. Circulation. 2000. No. 102. P. 2031–2037. DOI: 10.1161/01.cir.102.17.2031.</mixed-citation><mixed-citation xml:lang="en">Morrow D. A., Antman E. M., Charlesworth A. et al. TIMI risk score for ST elevation myocardial infarction: a convenient, beside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infracting myocardium early II trial substudy. Circulation. 2000. No. 102. P. 2031–2037. DOI: 10.1161/01.cir.102.17.2031.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Amal Hafez Ahmed, Amr elHadidy, Mohamed Helmy, Ashraf Hussein, Abdalla Elagha. Myocardial perfusion grade by coronary angiography can predict final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy. Open Access Maced J Med Sci &amp; 2021 Mar 01; 9 (B): 184–190.</mixed-citation><mixed-citation xml:lang="en">Amal Hafez Ahmed, Amr elHadidy, Mohamed Helmy, Ashraf Hussein, Abdalla Elagha. Myocardial perfusion grade by coronary angiography can predict final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy. Open Access Maced J Med Sci &amp; 2021 Mar 01; 9 (B): 184–190.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jose P. S. Henriques, Felix Zijlstra, Arnoud W. J. van’t Hof, Menko-Jan de Boer, Jan-Henk E. Dambrink, Marsel Gosselink et al (2003). Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2203; 107 C &amp; 2115–19. https://doi.org/10.1161/01.CIR.0000065221.06430.ED</mixed-citation><mixed-citation xml:lang="en">Jose P. S. Henriques, Felix Zijlstra, Arnoud W. J. van’t Hof, Menko-Jan de Boer, Jan-Henk E. Dambrink, Marsel Gosselink et al (2003). Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2203; 107 C &amp; 2115–19. https://doi.org/10.1161/01.CIR.0000065221.06430.ED</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cyrus Vahdatpour, MD; David Collins, MD; Sheldon Goldberg, MD, FACC. Cardiogenic Shock. Journal of the American Heart Assosiation. 2019; 8e011991. DOI: 10.1161/JAHA.119.011991</mixed-citation><mixed-citation xml:lang="en">Cyrus Vahdatpour, MD; David Collins, MD; Sheldon Goldberg, MD, FACC. Cardiogenic Shock. Journal of the American Heart Assosiation. 2019; 8e011991. DOI: 10.1161/JAHA.119.011991</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
